2015
DOI: 10.1016/j.jss.2014.12.018
|View full text |Cite
|
Sign up to set email alerts
|

Penehyclidine hydrochloride postconditioning on lipopolysaccharide-induced acute lung injury by inhibition of inflammatory factors in a rodent model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 45 publications
1
13
0
Order By: Relevance
“…The protection of pharmacologic post-conditioning with PHC is limited by a “ceiling effect”. 27 Both VNS and treatment with acetylcholine or pseudocholinesterase are capable of suppressing LPS-induced systemic inflammatory response syndrome, as well decreasing release of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, and has been termed as “cholinergic anti-inflammatory pathway”. 28 Therefore, Wang et al hypothesized that PHC, an anticholinergic drug similar to atropine, suppresses the cholinergic anti-inflammatory pathway and abolishes pulmonary protective effects at higher concentrations.…”
Section: Resultsmentioning
confidence: 99%
“…The protection of pharmacologic post-conditioning with PHC is limited by a “ceiling effect”. 27 Both VNS and treatment with acetylcholine or pseudocholinesterase are capable of suppressing LPS-induced systemic inflammatory response syndrome, as well decreasing release of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6, and has been termed as “cholinergic anti-inflammatory pathway”. 28 Therefore, Wang et al hypothesized that PHC, an anticholinergic drug similar to atropine, suppresses the cholinergic anti-inflammatory pathway and abolishes pulmonary protective effects at higher concentrations.…”
Section: Resultsmentioning
confidence: 99%
“…15,16 Many recent studies of PHC have proposed that it might be beneficial for LPS-induced ALI disorders. [22][23][24][25] Previous research demonstrated that preconditioning with PHC could reduce pulmonary microvascular endothelial injury from LPS-induced ALI. 22,23 Additional reports demonstrated that PHC could moderately reduce LPSinduced ALI through the inhibition of the mitogen-activated protein kinase (MAPK) family and NF-kappa B levels in rats.…”
Section: Discussionmentioning
confidence: 99%
“…22,23 Additional reports demonstrated that PHC could moderately reduce LPSinduced ALI through the inhibition of the mitogen-activated protein kinase (MAPK) family and NF-kappa B levels in rats. 24,25 In addition to the aforementioned distinct biological changes, cell apoptosis is a generally acknowledged cause of LPS-induced ALI. 32,33 Different research methodologies demonstrated that ERS has a significant effect on the mechanisms of several lung disorders including LPS-induced ALI and lung fibrosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…An increasing number of studies have indicated that PHC exhibits anti-apoptotic, anti-inflammatory and anti-oxidative stress effects under organ dysfunction (16,32,33). A previous study demonstrated that PHC exerted anti-inflammatory properties and protective effects during ALI via the inhibition of the toll-like receptor 4 signaling pathway (34). Furthermore, Cao et al (35) confirmed that PHC alleviated cerebral injury by inhibiting the p38 mitogen-activated protein kinase (MAPK) and caspase-3.…”
Section: Discussionmentioning
confidence: 99%